Loading patent…
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Soo Youn Jun, An Sung Kwon, Soon Hye Hwang, Hyun Min Song, Ji In Jung, Sang Hyeon Kang
Estimating the term…
The present invention relates to Siphoviridae bacteriophage Vib-ANP-1(accession number KCTC 13075BP) having the ability to specifically kill Vibrio anguillarum bacteria and a genome represented by SEQ ID NO: 1 and isolated from nature, and a method for prevention or treatment of Vibrio anguillarum bacterial infection by using a composition containing the same bacteriophage as an effective ingredient.
A feed additive composition comprising maltodextrin and 1×104 pfu/ml to 1×1015 pfu/ml or 1×104 pfu/g to 1×1015 pfu/g of Siphoviridae bacteriophage Vib-ANP-1 that has a specific antibacterial activity against Vibrio anguillarum and a 213.97 kb size of genome expressed by a nucleotide sequence of SEQ ID NO:1, and is deposited as accession number of KCTC 13075BP.
A method for suppressing diseases caused by Vibrio anguillarum, or alleviating the pathological condition of the diseases caused by Vibrio anguillarum, wherein the method comprises a step of administering to an animal other than a human a composition comprising maltodextrin and 1×104 pfu/ml to 1×1015 pfu/ml or 1×104 pfu/g to 1×1015 pfu/g of Siphoviridae bacteriophage Vib-ANP-1 (Accession number:
Dependencies are inferred from the claim text.